|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 711.70 USD | +2.34% |
|
+8.18% | -8.63% |
| 09:12pm | Regeneron Pharmaceuticals, Inc., Q2 2026 Earnings Call, Jul 30, 2026 | |
| 08:24pm | Sanofi Shares Slide After CEO Signals Challenges to Fill Drug Pipeline | DJ |
| Market Cap | 7.08TCr 6.15TCr 5.71TCr 5.26TCr 9.91TCr 6,75500Cr 10TCr 68TCr 26TCr 3,35500Cr 27TCr 26TCr 11,28100Cr | P/E 2026 * |
18.4x | P/E 2027 * | 14.6x |
|---|---|---|---|---|---|
| Enterprise Value | 6.29TCr 5.47TCr 5.08TCr 4.68TCr 8.82TCr 6,00800Cr 8.98TCr 60TCr 24TCr 2,98400Cr 24TCr 23TCr 10,03400Cr | EV / Sales 2026 * |
3.96x | EV / Sales 2027 * | 3.42x |
| Free-Float |
72.33% | Yield 2026 * |
0.56% | Yield 2027 * | 0.64% |
Last Transcript: Regeneron Pharmaceuticals, Inc.
| 1 day | +2.35% | ||
| 1 week | +8.18% | ||
| Current month | +13.10% | ||
| 1 month | +13.10% | ||
| 3 months | -0.26% | ||
| 6 months | -4.89% | ||
| Current year | -8.63% |
| 1 week | 654.05 |  | 720.94 |
| 1 month | 623.89 | | 720.94 |
| Current year | 591.52 | | 821.11 |
| 1 year | 541 | | 821.11 |
| 3 years | 476.49 | | 1,211.2 |
| 5 years | 476.49 | | 1,211.2 |
| 10 years | 271.37 | | 1,211.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
| President | 66 | 01/01/2001 | |
| Chief Executive Officer | 73 | 08/01/1988 | |
| Director of Finance/CFO | 55 | 05/02/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 73 | 09/06/2023 | |
Michael Brown
BRD | Director/Board Member | 85 | 01/06/1991 |
Joseph Goldstein
BRD | Director/Board Member | 85 | 01/06/1991 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 02/07/26 | Sell | Director | -200 | 0.0002% | ||
| 19/02/26 | Fiscal year | Director | 4,914 | 0.0048% | ||
| 09/02/26 | Fiscal year | SVP Controller | 4,036 | 0.0039% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.34% | +8.18% | +27.16% | -4.95% | 7.08TCr | |
| -13.51% | -10.70% | +17.04% | +169.50% | 5.44TCr | |
| +3.25% | +52.70% | +52.70% | +52.70% | 4.72TCr | |
| -0.11% | +8.47% | -52.97% | -52.04% | 4.25TCr | |
| -1.31% | +2.71% | +62.71% | -23.74% | 3.09TCr | |
| -3.83% | +4.70% | +57.55% | +91.75% | 2.58TCr | |
| +4.27% | -0.44% | +76.58% | -51.75% | 2.16TCr | |
| -1.78% | -4.50% | -11.86% | +140.71% | 1.99TCr | |
| -2.61% | -1.93% | +78.28% | +132.31% | 1.63TCr | |
| -0.13% | +3.10% | +69.03% | +129.42% | 1.69TCr | |
| Average | -1.33% | +2.90% | +37.62% | +58.39% | 3.46TCr | |
| Weighted average by Cap. | -1.57% | +3.87% | +29.95% | +48.52% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.59TCr 1.38TCr 1.28TCr 1.18TCr 2.23TCr 1,51600Cr 2.27TCr 15TCr 5.94TCr 75TCr 5.97TCr 5.83TCr 2,53300Cr | 1.76TCr 1.53TCr 1.42TCr 1.31TCr 2.47TCr 1,68200Cr 2.51TCr 17TCr 6.59TCr 84TCr 6.62TCr 6.47TCr 2,80900Cr |
| Net income | 399.04Cr 346.61Cr 321.87Cr 296.84Cr 559.15Cr 38TCr 569.28Cr 3.81TCr 1.49TCr 19TCr 1.5TCr 1.47TCr 64TCr | 506.34Cr 439.81Cr 408.41Cr 376.66Cr 709.49Cr 48TCr 722.35Cr 4.84TCr 1.89TCr 24TCr 1.9TCr 1.86TCr 81TCr |
| Net Debt | -782.28Cr -679.49Cr -630.99Cr -581.92Cr -1.1TCr -75TCr -1.12TCr -7.47TCr -2.92TCr -37TCr -2.94TCr -2.87TCr -1,24700Cr | -1.05TCr -913.15Cr -847.97Cr -782.04Cr -1.47TCr -1,00400Cr -1.5TCr -10TCr -3.93TCr -50TCr -3.95TCr -3.86TCr -1,67600Cr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/26/30 | $706.63 | +1.61% | 5,40,582 |
| 29/26/29 | $695.42 | +0.03% | 10,22,421 |
| 28/26/28 | $695.18 | +4.20% | 9,00,408 |
| 27/26/27 | $667.17 | +1.70% | 6,50,984 |
| 24/26/24 | $656.01 | +0.63% | 7,08,392 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- REGN Stock
Select your edition
All financial news and data tailored to specific country editions
